Concourse Financial Group Securities’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2414 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4052 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4045 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4084 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4097 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4036 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3999 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3960 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3868 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3833 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3614 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3664 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3613 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3740 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3691 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3589 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3514 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3439 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3279 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3182 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3215 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3158 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2871 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3199 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3179 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3062 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2646 |
|